Page 6 - Janx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Janx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Janx Today - Breaking & Trending Today

Janux Therapeutics (NASDAQ:JANX) Trading Down 5.6%

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) shares were down 5.6% on Monday . The company traded as low as $14.19 and last traded at $14.54. Approximately 30,984 shares were traded during trading, a decline of 71% from the average daily volume of 107,982 shares. The stock had previously closed at $15.41. Wall Street Analyst […] ....

United States , Blackrock Inc , Janux Therapeutics Company Profile , Northern Trust Corp , Geode Capital Management , Vanguard Group Inc , Janux Therapeutics Inc , Janux Therapeutics , Get Rating , Therapeutics Stock Down , Capital Management , Street Corp , Trust Corp , Tumor Activatedt Cell Engager , Janux Therapeutics Daily , Nasdaq Janx ,

Janux Therapeutics (NASDAQ:JANX) Trading Up 6%

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating)’s share price was up 6% on Tuesday . The company traded as high as $15.94 and last traded at $15.79. Approximately 12,055 shares traded hands during trading, a decline of 89% from the average daily volume of 110,751 shares. The stock had previously closed at $14.89. Wall Street […] ....

United States , Metlife Investment Management , Barclays Plc , Sg Americas Securities , American International Group Inc , Janux Therapeutics Inc , Janux Therapeutics , Get Rating , International Group , Life Investment Management , Tumor Activatedt Cell Engager , Janux Therapeutics Daily , Nasdaq Janx ,

Janux Therapeutics (NASDAQ:JANX) Research Coverage Started at Wedbush

Wedbush started coverage on shares of Janux Therapeutics (NASDAQ:JANX – Get Rating) in a research report report published on Wednesday morning, The Fly reports. The firm issued an outperform rating and a $24.00 price objective on the stock. Several other research analysts have also recently commented on JANX. Bank of America decreased their target price […] ....

United States , Metlife Investment Management , York Mellon Corp , Blackrock Inc , Janux Therapeutics Company Profile , Janux Therapeutics Inc , Jpmorgan Chase Co , Janux Therapeutics , Get Rating , New York Mellon Corp , Life Investment Management , Tumor Activatedt Cell Engager , Janux Therapeutics Daily , Nasdaq Janx , Initiated Coverage ,

Janux Therapeutics (NASDAQ:JANX) Trading Up 3.2%

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating)’s stock price was up 3.2% during mid-day trading on Wednesday . The company traded as high as $12.06 and last traded at $12.03. Approximately 5,567 shares traded hands during trading, a decline of 95% from the average daily volume of 118,742 shares. The stock had previously closed at […] ....

United States , Vanguard Group Inc , Janux Therapeutics Inc , Blackrock Inc , Geode Capital Management , Janux Therapeutics , Get Rating , Capital Management , Woodline Partners , Tumor Activatedt Cell Engager , Janux Therapeutics Daily , Nasdaq Janx ,

Janux Therapeutics (NASDAQ:JANX) Now Covered by Wedbush

Investment analysts at Wedbush initiated coverage on shares of Janux Therapeutics (NASDAQ:JANX – Get Rating) in a note issued to investors on Wednesday, The Fly reports. The brokerage set an “outperform” rating on the stock. A number of other research firms also recently commented on JANX. TheStreet downgraded shares of Janux Therapeutics from a “c-” […] ....

United States , Janux Therapeutics Inc , Metlife Investment Management , Jpmorgan Chase Co , York Mellon Corp , Blackrock Inc , Janux Therapeutics , Get Rating , New York Mellon Corp , Life Investment Management , Tumor Activatedt Cell Engager , Janux Therapeutics Daily , Nasdaq Janx , Initiated Coverage ,